Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154740 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Yusang Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physical Examination Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China. Hauptthemen laut MEDLINE: Hypertension, Microbiota, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 221 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Neurogenic hypertension, a complex and multifactorial cardiovascular disorder, is known to be influenced by various genetic, environmental, and lifestyle factors. In recent years, there has been growing interest in the role of the gut microbiome in hypertension pathogenesis. The bidirectional communication between the gut microbiota and the central nervous system, known as the microbiota-gut-brain axis, has emerged as a crucial mechanism through which the gut microbiota exerts its influence on neuroinflammation, immune responses, and blood pressure regulation. Recent studies have shown how the microbiome has a substantial impact on a variety of physiological functions, such as cardiovascular health. The increased sympathetic activity to the gut may cause microbial dysbiosis, increased permeability of the gut, and increased inflammatory reactions by altering a number of intestinal bacteria producing short-chain fatty acids (SCFAs) and the concentrations of lipopolysaccharide (LPS) in the plasma. Collectively, these microbial metabolic and structural compounds stimulate sympathetic stimulation, which may be an important stage in the onset of hypertension. The result is an upsurge in peripheral and central inflammatory response. In addition, it has recently been shown that a link between the immune system and the gut microbiota might play a significant role in hypertension. The therapeutic implications of the gut microbiome including probiotic usage, prebiotics, dietary modifications, and fecal microbiota transplantation in neurogenic hypertension have also been found. A large body of research suggests that probiotic supplementation might help reduce chronic inflammation and hypertension that have an association with dysbiosis in the gut microbiota. Overall, this review sheds light on the intricate interplay between the gut microbiome and neurogenic hypertension, providing valuable insights for both researchers and clinicians. As our knowledge of the microbiome's role in hypertension expands, novel therapeutic strategies and diagnostic biomarkers may pave the way for more effective management and prevention of this prevalent cardiovascular disorder. Exploring the potential of the microbiome in hypertension offers an exciting avenue for future research and offers opportunities for precision medicine and improved patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Physical Examination Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
- Department of Cardiology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
- Department of Pediatric Diseases, N.F. Filatov Clinical Institute of Children's Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), Russia.
- Institute of Dentistry, Department of Pediatric, Preventive Dentistry and Orthodontics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Russia.
- Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: sajadkarampour1987@gmail.com.
- Venom and Biotherapeutics Molecules Lab, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. Electronic address: rasul.micro92@gmail.com.
Förderung
- National Institutes of Health
Zitieren
APA
Dai, Y., Shen, Z., Khachatryan, L. G., Vadiyan, D. E., Karampoor, S., & Mirzaei, R. (2023). Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154740
Vancouver
Dai Y, Shen Z, Khachatryan LG, Vadiyan DE, Karampoor S, Mirzaei R. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154740
BibTeX
@article{Dai2023,
author = {Dai, Yusang and Shen, Zheng and Khachatryan, Lusine G and Vadiyan, Diana E and Karampoor, Sajad and Mirzaei, Rasoul},
title = {Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154740}
}
EUVIMED